Government Operations Results for December 2019

Date: February 03, 2020

For the period of April to December 2019, the GOJ reported Total Revenues & Grants of $468.43 billion, $9.67 billion more than the Government’s projection. Furthermore, year over year, this represents an increase of approximately 7.1% relative to the $437.30 billion recorded for the corresponding period in 2018. ‘Tax Revenue’, ‘Non-Tax Revenue’ and ‘Capital Revenues’ outperformed projections during the review period, while ‘Grants’ underperformed projections during the period. ‘Tax Revenue’ amounted to $414.75 billion, $7.68 billion more than budgeted while ‘Non-Tax Revenue’ of $48.96 billion was reported; $2.10 billion more than budgeted. Furthermore, ‘Capital Revenues’ totalled $826.3 million, $13 million or 1.6% more than budgeted. ‘Grants’ underperformed the budget by $124.3 million, amounting to $3.89 billion during the review period. Notably, no provisional amount was booked for ‘Bauxite Levy’ for the review period.

Expenditures

Total Expenditure for the period April to December 2019 amounted to $445.02 billion, $11.77 billion or 2.6% less than the budgeted amount of $456.79 billion. Recurrent expenditure which totalled $404.81 billion, accounted for 90.96% of overall expenditures. Relative to projections, recurrent expenditure was $5.71 billion (1.4%) less than budgeted. Of the recurrent expenditure categories for the review period, all categories were below the budgeted amount. ‘Programmes’ amounted to $157.72 billion which was $1.59 billion or 1.0% less than projected. Similarly, ‘Compensation of Employees’ which amounted to $158.52 billion was $813.10 million or 0.5% less than projected. In addition, ‘Employee Contribution’ totalled $11.29 billion, 5.8% less than the budgeted amount of $11.99 billion. Wages & Salaries’ amounted to $147.22 billion and was $120.50 million or 0.1% less than projected.

As a result of the decrease in Expenditures for the period April to December 2019, the ‘Fiscal Surplus’ was $23.40 billion, relative to a projected surplus of $1.96 billion. Additionally, the primary balance for the period amounted to $111.98 billion, 19.3% more than budgeted.

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_453968572
January 30, 2026   Caribbean Assurance Brokers Limited (CABROKERS) has advised that Ms. Donna Brown, who currently serves as Chief Operatin…
shutterstock_453968572
January 30, 2026   NCB Financial Group Limited (NCBFG) has advised that the Board of Directors is scheduled to meet on Thursday, February 1…
shutterstock_148562033
January 30, 2026   Image Plus Consultants Limited (IPCL) has advised that a connected party purchased a total of 11,000 IPCL shares during …
shutterstock_453968572
January 30, 2026   Kingston: Dolla Financial Services Limited (“DOLLA”), issuer of the invitation for subscription of its public Bond Offer…
shutterstock_453968572
January 29, 2026   Kintyre Holdings (JA) Limited (KNTYR) has advised that it has acquired additional shares in Kulcha Rum, increasing its o…
shutterstock_537598660
January 30, 2026 Indies Pharma Jamaica Limited (INDIES) Audited financials for the twelve months ended October 31, 2025 Indies Pharma Jamai…
Margin Loan Facility
Hambani Estates Reaches Key Construction Milestone…
shutterstock_148562033
January 29, 2026   Supreme Ventures Limited (SVL) has advised that on January 28, 2026, a Director purchased 319,424 SVL shares and a relat…